These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 31160009)

  • 1. Automated extraction of sudden cardiac death risk factors in hypertrophic cardiomyopathy patients by natural language processing.
    Moon S; Liu S; Scott CG; Samudrala S; Abidian MM; Geske JB; Noseworthy PA; Shellum JL; Chaudhry R; Ommen SR; Nishimura RA; Liu H; Arruda-Olson AM
    Int J Med Inform; 2019 Aug; 128():32-38. PubMed ID: 31160009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sudden cardiac death in childhood RASopathy-associated hypertrophic cardiomyopathy: Validation of the HCM risk-kids model and predictors of events.
    Boleti OD; Roussos S; Norrish G; Field E; Oates S; Tollit J; Nepali G; Bhole V; Uzun O; Daubeney PEF; Stuart GA; Fernandes P; McLeod K; Ilina M; Liaqath MNA; Bharucha T; Delle Donne G; Brown E; Linter K; Khodaghalian B; Jones C; Searle J; Mathur S; Boyd N; Reindhardt Z; Duignan S; Prendiville T; Adwani S; Zenker M; Wolf CM; Kaski JP
    Int J Cardiol; 2023 Dec; 393():131405. PubMed ID: 37777071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden cardiac death in patients with hypertrophic cardiomyopathy: from bench to bedside with an emphasis on genetic markers.
    Marian AJ
    Clin Cardiol; 1995 Apr; 18(4):189-98. PubMed ID: 7788945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.
    O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM
    Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).
    O'Mahony C; Jichi F; Pavlou M; Monserrat L; Anastasakis A; Rapezzi C; Biagini E; Gimeno JR; Limongelli G; McKenna WJ; Omar RZ; Elliott PM;
    Eur Heart J; 2014 Aug; 35(30):2010-20. PubMed ID: 24126876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the relationship between the ambulatory electrocardiography-based micro T-wave alternans and the predicted risk score of sudden cardiac death at 5 years in patients with hypertrophic cardiomyopathy.
    Özyılmaz S; Püşüroğlu H
    Anatol J Cardiol; 2018 Sep; 20(3):165-173. PubMed ID: 30152798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.
    Ruiz-Salas A; García-Pinilla JM; Cabrera-Bueno F; Fernández-Pastor J; Peña-Hernández J; Medina-Palomo C; Barrera-Cordero A; De Teresa E; Alzueta J
    Europace; 2016 May; 18(5):773-7. PubMed ID: 25855675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of sudden cardiac death in hypertrophic cardiomyopathy.
    Hong Y; Su WW; Li X
    Curr Opin Cardiol; 2022 Jan; 37(1):15-21. PubMed ID: 34636345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the new American College of Cardiology/American Heart Association Guidelines for the risk stratification of sudden cardiac death in a large Mediterranean cohort with Hypertrophic Cardiomyopathy.
    Zegkos T; Tziomalos G; Parcharidou D; Ntelios D; Papanastasiou CA; Karagiannidis E; Gossios T; Rouskas P; Katranas S; Paraskevaidis S; Karvounis H; Efthimiadis G
    Hellenic J Cardiol; 2022; 63():15-21. PubMed ID: 34147674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].
    Li WX; Liu LW; Wang J; Zuo L; Yang F; Kang N; Lei CH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1033-1038. PubMed ID: 29325362
    [No Abstract]   [Full Text] [Related]  

  • 11. Sudden cardiac death in childhood hypertrophic cardiomyopathy is best predicted by a combination of electrocardiogram risk-score and HCMRisk-Kids score.
    Östman-Smith I; Sjöberg G; Alenius Dahlqvist J; Larsson P; Fernlund E
    Acta Paediatr; 2021 Nov; 110(11):3105-3115. PubMed ID: 34314540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management.
    Brignole M; Cecchi F; Anastasakis A; Crotti L; Deharo JC; Elliott PM; Fedorowski A; Kaski JP; Limongelli G; Maron MS; Olivotto I; Ommen SR; Parati G; Shen W; Ungar A; Wilde A
    Int J Cardiol; 2023 Jan; 370():330-337. PubMed ID: 36309161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Vriesendorp PA; Schinkel AF; Liebregts M; Theuns DA; van Cleemput J; Ten Cate FJ; Willems R; Michels M
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):829-35. PubMed ID: 25922410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden death related cardiomyopathies - Hypertrophic cardiomyopathy.
    Goff ZD; Calkins H
    Prog Cardiovasc Dis; 2019; 62(3):212-216. PubMed ID: 31004609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR.
    Avanesov M; Münch J; Weinrich J; Well L; Säring D; Stehning C; Tahir E; Bohnen S; Radunski UK; Muellerleile K; Adam G; Patten M; Lund G
    Eur Radiol; 2017 Dec; 27(12):5136-5145. PubMed ID: 28616729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the association between the presence of fragmented QRS and the predicted risk score of sudden cardiac death at 5 years in patients with hypertrophic cardiomyopathy.
    Özyılmaz S; Akgül Ö; Uyarel H; Pusuroğlu H; Karayakalı M; Gül M; Çetin M; Satılmışoğlu H; Yıldırım A; Bakır İ
    Anatol J Cardiol; 2017 Jul; 18(1):54-61. PubMed ID: 28559533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy.
    He D; Ye M; Zhang L; Jiang B
    Heart Lung; 2018; 47(2):122-126. PubMed ID: 29174363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Klopotowski M; Kukula K; Malek LA; Spiewak M; Polanska-Skrzypczyk M; Jamiolkowski J; Dabrowski M; Baranowski R; Klisiewicz A; Kusmierczyk M; Jasinska A; Jarmus E; Kruk M; Ruzyllo W; Witkowski A; Chojnowska L
    J Cardiol; 2016 Jul; 68(1):49-56. PubMed ID: 26363820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.
    Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J
    Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural language processing for identification of hypertrophic cardiomyopathy patients from cardiac magnetic resonance reports.
    Dewaswala N; Chen D; Bhopalwala H; Kaggal VC; Murphy SP; Bos JM; Geske JB; Gersh BJ; Ommen SR; Araoz PA; Ackerman MJ; Arruda-Olson AM
    BMC Med Inform Decis Mak; 2022 Oct; 22(1):272. PubMed ID: 36258218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.